300086.SZ
Honz Pharmaceutical Co., Ltd.
SZSE · Healthcare · C 制造业 · CN
CNY 6.42
−3.02%Margins
Gross margin
56.3%
EBITDA margin
-40.2%
EBIT margin
-56.3%
Net margin
-51.6%
FCF margin
7.9%
-26.2%
Return on equity
-13.4%
Return on assets
-20.4%
Return on invested capital
0.26x
Asset turnover
CNY 57.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026